Published in Hospital Business Week, April 8th, 2007
"Lasamide (2,4-dichloro-5-sulfamoylbenzoic acid) is one of them (along with its precursors). Five patients from a lasamide production line with suspected occupational asthma and rhinitis were examined. During the first visit, skin prick tests, total immunoglobulin E (IgE), a nonspecific bronchoprovocation test, and specific...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week